- Publication between 1975 - 2022
- A primary study with a direct comparison of patients undergoing ACLR with LB as an adjunctive to a comparable group not receiving LB
- Level I evidence only
|
- Absence of study of liposomal bupivacaine in the context of ACLR
- Retrospective studies, cohort studies, Case series, case reports, expert opinion, or other Level II, III, IV, or V evidence
|